PCN188 - ASSESSING THE ROBUSTNESS OF A COST-EFFECTIVENESS ANALYSIS OF LENVATINIB VERSUS SORAFENIB IN UNRESECTABLE HEPATOCELLULAR CARCINOMA IN JAPAN
Ikeda, S., Kudo, M., Izumi, N., Kaneko, S., Kobayashi, M., Azuma, M., Copher, R., Virabhak, S., Mitchell, D., Meier, G., Ishii, M.Volume:
21
Journal:
Value in Health
DOI:
10.1016/j.jval.2018.09.270
Date:
October, 2018
File:
PDF, 443 KB
2018